Short-term and intermittent ECG-based screening for atrial fibrillation in older adults without known atrial fibrillation: a GRADE-assessed meta-analysis of randomized trials with time-to-event data
In brief
ECG screening finds 76% more atrial fibrillation, but not fewer strokes
In seven randomized trials involving 77,526 older adults, short-term or intermittent ECG screening increased new atrial fibrillation diagnoses by 76% and new blood thinner use by 78%. It did not significantly reduce stroke, death, or major bleeding, and the evidence remains inconclusive, supporting cautious, risk-based screening rather than screening everyone.
- Journal
- Aging clinical and experimental research (Q2)
- Published
- 17 August 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Mohamed Saad Rakab, Abdalhakim Shubietah, Ahmed Emara, Elsayed Balbaa, Hamza A Abdul-Hafez, Belal Mohamed Hamed, et al.
- PMID
- 43052606
- DOI
- 10.1007/s40520-026-03478-1
Why clinicians should know about it
- Picked for Public Health, Environmental and Occupational Health (top studies of the week, 22 November 2026): Population screening benefits and harms for atrial fibrillation
Abstract
BACKGROUND: Non-invasive ECG-based screening for atrial fibrillation (AF) in older adults may increase detection of silent AF and uptake of oral anticoagulation (OAC), but screening strategies, AF definitions, AF burden, and downstream treatment thresholds vary across trials. METHODS: We performed a a GRADE-assessed meta-analysis of randomized controlled trials (RCTs) comparing short-term or intermittent non-invasive ECG-based AF screening strategies versus usual care, opportunistic detection, or no invitation in older adults without known AF. For dichotomous outcomes, pooled risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using random-effects models. Trial sequential analysis (TSA) assessed conclusiveness of evidence. RESULTS: Across seven RCTs involving 77,526 participants (38,770 assigned to ECG-based screening and 38,756 to control group), screening increased new AF diagnoses compared with control (RR 1.76, 95% CI 1.21-2.56; moderate-certainty). ECG-based screening also increased new OAC initiation (RR 1.78, 95% CI 1.13-2.81; moderate-certainty). However, there were no significant differences in stroke or systemic embolism (RR 0.95, 95% CI 0.89-1.01), all-cause mortality (RR 0.98, 95% CI 0.95-1.02), or major bleeding (RR 0.98, 95% CI 0.92-1.05). Exploratory subgroup analyses by screening framework did not show statistically significant subgroup differences for AF detection, stroke/systemic embolism, mortality, or major bleeding. TSA indicated that evidence for AF detection and clinical outcomes remains inconclusive. CONCLUSIONS: Short-term and intermittent ECG-based AF screening in older adults without known AF increases trial-defined AF detection and OAC initiation but has not demonstrated reductions in stroke, mortality, or major bleeding. Current evidence supports a cautious, risk-based screening approach rather than broad population-wide implementation.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.